| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $128K | -11.9% | +40.2% |
| SG&A Expense | $2.8M | -11.1% | +2.2% |
| Operating Income | -$2.9M | +11.1% | -3.4% |
| Pre-tax Income | -$2.2M | +13.4% | +10.6% |
| Income Tax | $104K | +468.8% | — |
| Net Income | -$1.2M | +8.3% | -48.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $59.4M | -4.2% | +174.3% |
| Accounts Receivable | $1.3M | +30.3% | +443.1% |
| Current Assets | $61.5M | -3.9% | +169.8% |
| Total Assets | $67.2M | -2.2% | +159.3% |
| Current Liabilities | $3.1M | +5.9% | -11.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | — |
| Capital Expenditures | $4.5M | — | — |
| Investing Cash Flow | -$1.5M | — | — |
| Financing Cash Flow | $49.4M | — | — |
| Free Cash Flow | -$12.0M | — | — |
| $3.1M |
| +5.3% |
| -13.3% |
| Stockholders' Equity | $64.0M | -2.6% | +187.3% |